MedTrace Logo

Interventions to Improve Colorectal Cancer Screening

NCT00692211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 404

Last updated 2015-05-13

Study results available
· View outcomes & findings →

Summary

We will evaluate if we can increase colorectal cancer screening rates by directly sending screening tests to patients rather than waiting for them to come to clinic visits. We are also evaluating a new test--fecal immunochemical tests--which does not require patients to make dietary or medication changes. We will see if patients are more likely to complete these tests than the standard fecal occult blood tests.

Conditions

  • Colorectal Neoplasms

Interventions

OTHER

Mailed fecal occult blood tests

Stool blood test

OTHER

Mailed fecal immunochemical tests

Stool blood test

Sponsors & Collaborators

Principal Investigators

  • Richard M Hoffman, MD · New Mexico VA Health Care System, Albuquerque, NM

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00692211 on ClinicalTrials.gov